Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza for Remodulin infusion site pain in PAH
NCT01393795Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Aug 2011
- Primary completion
- Jul 2012
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capsaicin 8% patch in pain, sponsored by Imperial College London. Started Aug 2011; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
pain
Beyond the preview
Go deeper on NCT01393795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393795.